Citrullinated ENO1 Vaccine Enhances PD-1 Blockade in Mice Implanted with Murine Triple-Negative Breast Cancer Cells

<b>Background/Objectives</b>:Cancer vaccine targets mostly include mutations and overexpressed proteins. However, cancer-associated post-translational modifications (PTMs) may also induce immune responses. Previously, our group established the enzyme protein arginine deiminase type-2 (PADI2), which...

Descripción completa

Detalles Bibliográficos

Autores principales:	Ricardo A. León-Letelier, Alejandro M. Sevillano-Mantas, Yihui Chen, Soyoung Park, Jody Vykoukal, Johannes F. Fahrmann, Edwin J. Ostrin, Candace Garrett, Rongzhang Dou, Yining Cai, Fu-Chung Hsiao, Jennifer B. Dennison, Eduardo Vilar, Banu K. Arun, Samir Hanash, Hiroyuki Katayama
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2025-06-01
Colección:	Vaccines
Materias:	cancer vaccine post-translational modification immunopeptidome triple-negative breast cancer PD-1 blockade
Acceso en línea:	https://www.mdpi.com/2076-393X/13/6/629
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!